Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Tanzania and Kenya

COVID-19 对坦桑尼亚和肯尼亚糖尿病患者的医疗保健和社会经济影响

• 批准号: MR/V035924/1
• 负责人: Sally Mtenga
• 金额: $ 113.31万
• 依托单位: Ifakara Health Institute (IHI)
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2021
• 资助国家: 英国
• 起止时间: 2021 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=MR%2FV035924%2F1
• 关键词: Healthcare; Socio; economic; Impacts; COVID

People with type 2 diabetes are known to be at increased risk of complications and death from COVID-19, and yet their healthcare has been disrupted by the pandemic. This could lead to more indirect COVID-19 related deaths. Tanzania and Kenya are experiencing increases in the numbers of people with type 2 diabetes, and their ability to manage their condition during COVID-19 may be hampered through lack of access to support, economic hardship and health system challenges. In addition, increased vulnerability may prevent patients seeking treatment, and experiences for people living in urban and rural areas and in the two countries may differ. There is therefore an urgent need to understand how COVID-19 has affected the healthcare and socio-economic welfare of people with type 2 diabetes in Tanzania and Kenya to inform policy recommendations and health education messages to improve health and welfare for this vulnerable population during the pandemic. This project will provide this evidence by administering questionnaires and interviews to people with type 2 diabetes and through interviews to healthcare providers in urban and rural settings in each country. It will also identify the cost of type 2 diabetes to each country during COVID-19 and gaps in national policy and emergency planning responses. The findings will be shared with relevant stakeholders to allow them to input into the development of context-specific policy recommendations and health messages for each country.

众所周知，2 型糖尿病患者因 COVID-19 而出现并发症和死亡的风险较高，但他们的医疗保健却受到了这一流行病的干扰。这可能会导致更多与 COVID-19 相关的间接死亡。坦桑尼亚和肯尼亚的 2 型糖尿病患者数量正在增加，而他们在 COVID-19 期间控制病情的能力可能会因缺乏支持、经济困难和卫生系统挑战而受到阻碍。此外，脆弱性的增加可能会阻碍患者寻求治疗，而且生活在城市和农村地区以及两国的人们的经历可能会有所不同。因此，迫切需要了解 COVID-19 如何影响坦桑尼亚和肯尼亚 2 型糖尿病患者的医疗保健和社会经济福利，以便为政策建议和健康教育信息提供信息，以改善这一弱势群体在大流行期间的健康和福利。该项目将通过对 2 型糖尿病患者进行问卷调查和访谈，以及对每个国家城乡环境中的医疗保健提供者进行访谈来提供这一证据。它还将确定 COVID-19 期间每个国家 2 型糖尿病的成本以及国家政策和应急计划应对措施的差距。研究结果将与相关利益攸关方分享，以便他们为每个国家制定适合具体情况的政策建议和健康信息提供意见。